719 Phase 1 clinical trial design of ZM008, a first-in-class anti LLT1 antibody is a promising therapy for multiple solid cancers oleh Ignacio Garcia-Ribas, Maloy Ghosh, Anurag Tiwari, Sanghamitra Bhattacharjee, Yogendra Manjunath, Shalini Kashipathi, Subith Krishna, Ashvini Kumar Dubey, Tirtha Mandal, Soorya Gnanasegaran